Needle-Free Drug Delivery 2018 Global Market Expected to Grow at CAGR 10.31% and Forecast to 2021
The analysts forecast the global needle free drug delivery market to grow at a CAGR of 10.31% during the period 2017-2021.
PUNE, INDIA, February 7, 2018 /EINPresswire.com/ --
Global Needle-Free Drug Delivery Market
Description
WiseGuyReports.Com adds” Global Needle-Free Drug Delivery Market 2017-2021 “Research To Its Database.
Needle free drug delivery technologies are used to deliver biologics such as insulin, vaccines, human growth hormone (HGH), and drugs for pain management into the patient’s body without using a traditional needle. Needle free drug delivery market includes jet injectors, transdermal drug delivery systems and other novel needle free devices that are used as alternatives to conventional needle drug delivery devices.
Covered in this report
The report covers the present scenario and the growth prospects of the global needle free drug delivery market for 2017-2021. To calculate the market size, the report considers sales and value.
Get sample Report @ https://www.wiseguyreports.com/sample-request/1431236-global-needle-free-drug-delivery-market-2017-2021
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
The Global Needle Free Drug Delivery Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Endo Pharmaceuticals
• Antares Pharma
• Inovio Pharmaceuticals
• Valeritas
• PharmaJet
Other prominent vendors
• 3M
• Akra Dermojet
• Consort Medical
• CROSSJECT
• Injex Pharma (acquired by Hangzhou Hema Medical Equipment)
• PenJet Corporation
• Zosano
• D’Antonio Consultants International
• European Pharma Group
Market driver
• Increasing incidence of needle stick injuries
• For a full, detailed list, view our report
Market challenge
• Technical complexities of needle free drug delivery devices
• For a full, detailed list, view our report
Market trend
• Increasing outsourcing
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
Complete Report Details @ https://www.wiseguyreports.com/reports/1431236-global-needle-free-drug-delivery-market-2017-2021
Table of Contents -Major Key Points
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
• Market outline
PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 06: Market segmentation by product/technology
• Jet injectors
• Market size and forecast
• Transdermal drug delivery systems
• Market size and forecast
• Others
• Market size and forecast
PART 07: Market segmentation by application
• Market segmentation by application
• Insulin delivery
• Vaccination
• Pain management
• Others
PART 08: Geographical segmentation
• Market overview
• Americas
• EMEA
• APAC
PART 09: Decision framework
PART 10: Drivers and challenges
• Market drivers
• Market challenges
PART 11: Market trends
• Technological innovations
• Increasing outsourcing
M&A and strategic collaborations
PART 12: Vendor landscape
• Competitive scenario
PART 13: Key vendor analysis
• Endo Pharmaceuticals
• Antares Pharma
• Inovio Pharmaceuticals
• Valeritas
• PharmaJet
• Other prominent vendors
………..CONTINUED
Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.